Study of Ovarian Reserve Concerning Patients With Multiple Sclerosis (MS), Compared to a Control Group
Study of Ovarian Reserve Concerning Patients With Multiple Sclerosis, Compared to a Control Group
University Hospital, Bordeaux
160 participants
Dec 4, 2023
INTERVENTIONAL
Conditions
Summary
The investigators want to evaluate ovarian reserve concerning patients with multiple sclerosis, compared to a control group of healthy women. This study will include women from 25 to 35 years old.
Eligibility
Plain Language Summary
Simplified for easier understanding
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Measure of Anti-Mullerian hormone (AMH) level by blood sample
Measure of Antral follicle count (AFC) by ultrasound imaging
MS history and MS treatments and Expanded Disability Status Scale (EDSS) score will be recorded
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05754593